Fighting Hepatitis To Tackle Liver Cancer – Survey Reveals National Deficiencies Which Make EU Action Critical

A survey conducted among Members of the European Liver Patients Association (ELPA) reveals that hepatitis awareness amongst national policymakers and the general public is very low. In view of this ignorance and neglect of a major disease at national level ELPA calls upon the EU to promote targeted screening strategies to ensure early diagnosis for […]

Liver Tumors Associated With Metabolic Syndrome Differ From Other Tumors

Liver cancer in patients whose only risk factor is metabolic syndrome has distinct forms and structures compared to other liver tumors. These findings are in the March issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also […]

Patients With Cirrhosis And Gene Variation May Have Elevated Risk Of Liver Tumor

A particular gene variation appears to significantly increase the risk that individuals with cirrhosis of the liver will go on to develop hepatocellular carcinoma (HCC), a liver tumor that is the third leading cause of cancer death. In the January 2 Journal of the American Medical Association, researchers from Massachusetts General Hospital (MGH) Cancer Center […]

Researchers Show That Fibrosis Can Be Stopped, Cured And Reversed

University of California, San Diego researchers have proven in animal studies that fibrosis in the liver can be not only stopped, but reversed. Their discovery, to be published in PLoS Online on December 26, opens the door to treating and curing conditions that lead to excessive tissue scarring such as viral hepatitis, fatty liver disease, […]

In Largest U.S. Hepatitis C Trial, Researchers Determine Weight-Based Dosing Is Key To Optimal Treatment

As reported recently in the journal Hepatology, WIN-R, a multicenter study of over 5,000 patients with hepatitis C virus (HCV) showed treatment with weight-based REBETOLĀ® (ribavirin, USP) (RBV) in combination with pegylated interferon (PEG-IFN) alfa-2b achieved significantly higher rates of sustained virologic response (SVR) and lower relapse rates compared to combination therapy using a flat […]

Possible New Way To Detect, Monitor Liver Disease Without Painful Liver Biopsy

Scientists working at the Hepatitis B Foundation, in partnership with Drexel University College of Medicine, think they may have discovered a reliable alternative to liver biopsy for the early detection of liver fibrosis and cirrhosis, which afflict more than 5 million Americans. People with hepatitis B and C infections, as well as fatty liver diseases, […]

Shorter Legs Linked To Liver Disease

Short legs are linked to an increased risk of liver disease, suggests a study in the Journal of Epidemiology and Community Health. The research contributes to a growing body of evidence on the link between leg length and health. The findings are based on almost 4300 women between the ages of 60 and 79, who […]

Medivir: Initiation Of A Phase IIa Clinical Trial With Investigational Hepatitis C Protease Inhibitor TMC435350

Medivir (STO:MVIRB) announced that, following the successful completion of a phase I study in both healthy volunteers and patients chronically infected with hepatitis C virus (HCV), the phase IIa study, TMC435350-C201, of the investigational hepatitis C (HCV) protease inhibitor TMC435350. The study will start shortly in Europe by Tibotec Pharmaceuticals Ltd., who are collaborating with […]

GNI Announces IND Approval In China For Novel Liver Disease Drug F351

GNI Ltd (TOKYO:2160), a leading biopharmaceutical company in Japan and China, is pleased to announce that the State Food and Drug Administration of China has approved its Investigational New Drug application (IND) for the clinical development of one of its lead drug candidates, F351, for the treatment of liver fibrosis/cirrhosis. GNI’s China-based affiliate, Shanghai Genomics, […]

The American Liver Foundation Encourages Heightened Awareness Of Hepatitis B And C In Light Of Recent Events In The News

The following release and statements are attributed to The American Liver Foundation: The American Liver Foundation, a nonprofit organization dedicated to raising awareness and improving the quality of life for the 30 million Americans with liver disease, issued a statement today expressing its concern over the recent reports that Nassau County physician Dr. Harvey Finkelstein […]